Pune Ayurvedic Firm Loses Licence

The Maharashtra Food and Drug Administration (FDA) has taken a significant step towards ensuring public health by cancelling the licence of an Ayurvedic medicine manufacturer in Pune. The decision was made after the company was found to have committed safety violations. This action highlights the FDA's commitment to enforcing strict quality control measures in the state's pharmaceutical industry. By cancelling the licence, the FDA aims to protect consumers from potentially harmful products. The move is expected to have a positive impact on the overall quality of Ayurvedic medicines available in the market.